Amrutanjan Health Care Ltd vs Parmax Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of Amrutanjan Health Care Ltd is ₹ 542.9 as of 08 May 16:01 . The P/E Ratio of Amrutanjan Health Care Ltd changed from 27.1 on March 2021 to 36.7 on March 2025 . This represents a CAGR of 6.25% over 5 yearsThe P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Amrutanjan Health Care Ltd changed from ₹ 1661 crore on March 2021 to ₹ 1864 crore on March 2025 . This represents a CAGR of 2.34% over 5 yearsThe Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 years The revenue of Amrutanjan Health Care Ltd for the Dec '25 is ₹ 145.16 crore as compare to the Sep '25 revenue of ₹ 122 crore. This represent the growth of 18.98% The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 4.33 crore as compare to the Sep '25 revenue of ₹ 2.54 crore. This represent the growth of 70.47% The ebitda of Amrutanjan Health Care Ltd for the Dec '25 is ₹ 28.04 crore as compare to the Sep '25 ebitda of ₹ 20.82 crore. This represent the growth of 34.68% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ -0.19 crore as compare to the Sep '25 ebitda of ₹ -1.58 crore. This represent the decline of -87.97% The net profit of Amrutanjan Health Care Ltd changed from ₹ 4.62 crore to ₹ 19.45 crore over 7 quarters. This represents a CAGR of 127.37% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.73 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Amrutanjan Health Care Ltd changed from 20.04 % on March 2021 to 26.15 % on March 2025 . This represents a CAGR of 5.47% over 5 yearsThe Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu.
The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research.
Three plants have been set up in the Alandur industrial belt near Chennai to produce these products.
It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
Pheromones have found wide application as pesticides and are used on cotton crops.

About Parmax Pharma Ltd

Incorporated in November, 1994, Parmax Pharma Limited (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
The Company has manufacturing facilities approved by Indian regulatory bodies such as CDSCO, State FDA, and operates under GMP-compliant systems. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

FAQs for the comparison of Amrutanjan Health Care Ltd and Parmax Pharma Ltd

Which company has a larger market capitalization, Amrutanjan Health Care Ltd or Parmax Pharma Ltd?

Market cap of Amrutanjan Health Care Ltd is 1,614 Cr while Market cap of Parmax Pharma Ltd is 11 Cr

What are the key factors driving the stock performance of Amrutanjan Health Care Ltd and Parmax Pharma Ltd?

The stock performance of Amrutanjan Health Care Ltd and Parmax Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amrutanjan Health Care Ltd and Parmax Pharma Ltd?

As of May 8, 2026, the Amrutanjan Health Care Ltd stock price is INR ₹558.6. On the other hand, Parmax Pharma Ltd stock price is INR ₹31.7.

How do dividend payouts of Amrutanjan Health Care Ltd and Parmax Pharma Ltd compare?

To compare the dividend payouts of Amrutanjan Health Care Ltd and Parmax Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.